Psoriatic arthritis: a dermatologist's perspective.
Psoriatic arthritis (PsA) is a common, destructive arthritis that may manifest in more than one-third of psoriasis patients. Dermatologists are in a unique position to diagnose PsA early, and to start prompt, effective treatment. Such early intervention with biological agents such as tumor necrosis factor alpha antagonists, which appear to hold particular promise in the long-term management of PsA, may significantly reduce morbidity, improve quality of life and substantially reduce the economic (patient and societal) burden of PsA.
Snyder
Robert Alan
RA
Dermatology Consultants of Broward, Pembroke Pines, FL, USA. rasnydermd@gmail.com
D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D017281:Cost of Illness; D003880:Dermatology / Q000379:methods*; D042241:Early Diagnosis; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D011788:Quality of Life; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha